arg-3-hyp-7-phe-bradykinin has been researched along with Blood Pressure, High in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbas, SA; Sharma, JN | 2 |
2 other study(ies) available for arg-3-hyp-7-phe-bradykinin and Blood Pressure, High
| Article | Year |
|---|---|
A bradykinin antagonist abolishes beneficial effect of captopril on duration of survival after acute coronary artery ligation in hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Bradykinin B2 Receptor Antagonists; Captopril; Coronary Vessels; Heart Rate; Hypertension; Ligation; Male; Rats; Rats, Inbred SHR; Survival Rate | 2005 |
Effect of captopril in the presence of kinin B2 receptor antagonist on duration of survival after prolonged coronary artery ligation in hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Bradykinin B2 Receptor Antagonists; Captopril; Coronary Vessels; Heart Rate; Hypertension; Ligation; Male; Rats; Rats, Inbred SHR; Survival Rate | 2006 |